معرفی
Adel Schwertani is a Professor in the Department of Medicine, Faculty of Medicine and Health Sciences at McGill University, and a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) at the Glen site. He is affiliated with the Cardiovascular Health Across the Lifespan Program within the Centre for Translational Biology and works in the Department of Medicine, Division of Cardiology at the MUHC.
Dr. Schwertani's research focuses on the role of vasoactive and structural proteins in the pathogenesis of cardiovascular diseases including atherosclerosis, myocardial infarction, aortic valve disease, and pulmonary hypertension. Along with his collaborators, he investigates the role of stem cells in cardiac regeneration and personalized drug testing. His laboratory recently identified a new mediator in the pathogenesis of thrombosis and is working with national and international collaborators to develop new therapeutic approaches for pulmonary emboli and deep vein thrombosis.
His publication record demonstrates consistent contributions to understanding the molecular mechanisms of cardiovascular disease, particularly in the areas of aortic valve stenosis, lipoprotein(a) effects on cardiovascular tissues, and novel approaches to cardiac repair. His work bridges basic science with clinical applications, focusing on translating laboratory findings into potential therapeutic strategies for cardiovascular conditions.
Dr. Schwertani actively collaborates with researchers across multiple institutions, as evidenced by his co-authorship on systematic reviews and meta-analyses of preclinical trials in cardiac regeneration. His research program appears to be well-integrated within the cardiovascular research community at McGill University and the RI-MUHC.